{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:45:50Z","timestamp":1791323150697,"version":"4.3.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-1-0253, W81XWH1910235"],"award-info":[{"award-number":["W81XWH-18-1-0253, W81XWH1910235"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henry Gustav Floren Trust"},{"DOI":"10.13039\/100007491","name":"Donald E. and Delia B. Baxter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Knut and Alice Wallenberg Foundation International Postdoctoral Scholarship Program","award":["KAW 2014.0412"],"award-info":[{"award-number":["KAW 2014.0412"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U19AI167903-01, 5U01AI165527-02, 1U19AI109662, U1"],"award-info":[{"award-number":["1U19AI167903-01, 5U01AI165527-02, 1U19AI109662, U1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19-AI110491, R01 AI125197-01"],"award-info":[{"award-number":["U19-AI110491, R01 AI125197-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI144292, U54GM104938, P30AR073750"],"award-info":[{"award-number":["UM1AI144292, U54GM104938, P30AR073750"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001845","name":"Scleroderma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001845","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boerhinger Ingelheim"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["N01-AI-05419"],"award-info":[{"award-number":["N01-AI-05419"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201100025C"],"award-info":[{"award-number":["HHSN272201100025C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["N01-AI-25481"],"award-info":[{"award-number":["N01-AI-25481"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272200900057C"],"award-info":[{"award-number":["HHSN272200900057C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1UM2AI117870"],"award-info":[{"award-number":["1UM2AI117870"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1136\/ard-2021-221926","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T18:21:26Z","timestamp":1674066086000},"page":"670-680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7843-2960","authenticated-orcid":false,"given":"Burcu","family":"Ayoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E","family":"Furst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie J","family":"Crofford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Goldmuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Keyes-Elstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9574-7355","authenticated-orcid":false,"given":"Judith","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Macwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen D","family":"Mayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McSweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-9216","authenticated-orcid":false,"given":"Keith M","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Pinckney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1236-0252","authenticated-orcid":false,"given":"Rong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4143-4708","authenticated-orcid":false,"given":"Purvesh","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Utz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2021-221926_bib1","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","article-title":"Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population","volume":"48","author":"Mayes","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2021-221926_bib2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2021-221926_bib3","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2021-221926_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard-2021-221926_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11926-004-0061-9","article-title":"Antibodies in scleroderma: direct pathogenicity and phenotypic associations","volume":"6","author":"Chung","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"10.1136\/ard-2021-221926_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13075-018-1569-0","article-title":"Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression","volume":"20","author":"Bosello","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2021-221926_bib7","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: a reappraisal","volume":"51","author":"O'Reilly","year":"2012","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2021-221926_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2249.2004.02647.x","article-title":"T cell repertoire in patients with stable scleroderma","volume":"139","author":"Tiev","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard-2021-221926_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2249.2006.03041.x","article-title":"Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin","volume":"144","author":"De Palma","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard-2021-221926_bib10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2004.027094","article-title":"Early T cell activation in the skin from patients with systemic sclerosis","volume":"64","author":"Kalogerou","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2021-221926_bib11","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2021-221926_bib12","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2021-221926_bib13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1136\/ard-2021-221926_bib14","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.40560","article-title":"Treatment algorithms for systemic sclerosis according to experts","volume":"70","author":"Fern\u00e1ndez-Codina","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2021-221926_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2021-221926_bib16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/annrheumdis-2019-215770","article-title":"Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures","volume":"78","author":"Assassi","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2021-221926_bib17","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/annrheumdis-2020-217033","article-title":"Machine learning predicts stem cell transplant response in severe scleroderma","volume":"79","author":"Franks","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2021-221926_bib18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/art.41570","article-title":"Large-Scale characterization of systemic sclerosis serum protein profile: comparison to peripheral blood cell transcriptome and correlations with skin\/lung fibrosis","volume":"73","author":"Bellocchi","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2021-221926_bib19","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard-2021-221926_bib20","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jaci.2017.10.003","article-title":"Biomarkers in connective tissue diseases","volume":"140","author":"Jog","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1136\/ard-2021-221926_bib21","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1158\/1078-0432.CCR-09-2424","article-title":"Viral response to chemotherapy in endemic Burkitt lymphoma","volume":"16","author":"Tang","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ard-2021-221926_bib22","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1056\/NEJMc076383","article-title":"Multiple autoimmune diseases after autologous stem-cell transplantation","volume":"357","author":"Bohgaki","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2021-221926_bib23","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/annrheumdis-2012-202729","article-title":"Development and resolution of secondary autoimmunity after autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: competition of plasma cells for survival niches?","volume":"72","author":"Alexander","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2021-221926_bib24","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood-2006-07-035766","article-title":"Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used","volume":"109","author":"Loh","year":"2007","journal-title":"Blood"},{"key":"10.1136\/ard-2021-221926_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/ard-2021-221925","article-title":"Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more na\u00efve state in patients with systemic sclerosis","volume":"82","author":"Adamska","year":"2023","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1136\/ard-2021-221926_bib26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-immunol-032713-120222","article-title":"Anticytokine autoantibody-associated immunodeficiency","volume":"32","author":"Browne","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/ard-2021-221926_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1136\/ard-2021-221926_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1136\/ard-2021-221926_bib29","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1038\/s41467-021-25509-3","article-title":"New-Onset IgG autoantibodies in hospitalized patients with COVID-19","volume":"12","author":"Chang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2021-221926_bib30","article-title":"Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infections. | research square","author":"Feng","year":"2022","journal-title":"medRxiv"},{"key":"10.1136\/ard-2021-221926_bib31","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/art.1780350814","article-title":"Anti-Interleukin-6 autoantibodies in rheumatic diseases. increased frequency in the sera of patients with systemic sclerosis","volume":"35","author":"Takemura","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2021-221926_bib32","first-page":"136","article-title":"Anti-Cytokine autoantibodies in autoimmune diseases","volume":"1","author":"Cappellano","year":"2012","journal-title":"Am J Clin Exp Immunol"},{"key":"10.1136\/ard-2021-221926_bib33","article-title":"Association between anti-interferon-alpha autoantibodies and COVID-19 in systemic lupus erythematosus","author":"Gupta","year":"2020","journal-title":"medRxiv"},{"key":"10.1136\/ard-2021-221926_bib34","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/ar3315","volume":"13","author":"Overbeek","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2021-221926_bib35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/BF02624011","article-title":"Stimulation by transforming growth factor-beta of epidermal growth factor-dependent growth of aged human fibro-blasts: recovery of high affinity EGE receptors and growth stimulation by EGF","volume":"25","author":"Kawamoto","year":"1989","journal-title":"In Vitro Cell Dev Biol"},{"key":"10.1136\/ard-2021-221926_bib36","first-page":"1463","article-title":"Epidermal growth factor receptor of fibroblasts from patients with scleroderma","volume":"17","author":"Tokiyama","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2021-221926_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/rccm.200811-1682OC","article-title":"Role of epidermal growth factor inhibition in experimental pulmonary hypertension","volume":"181","author":"Dahal","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard-2021-221926_bib38","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/CIRCULATIONAHA.105.540542","article-title":"Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension","volume":"112","author":"Merklinger","year":"2005","journal-title":"Circulation"},{"key":"10.1136\/ard-2021-221926_bib39","doi-asserted-by":"crossref","first-page":"e89073","DOI":"10.1172\/jci.insight.89073","article-title":"Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity","volume":"1","author":"Lofgren","year":"2016","journal-title":"JCI Insight"},{"key":"10.1136\/ard-2021-221926_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1096\/fj.01-0847com","article-title":"Autoantibodies to the epidermal growth factor receptor in systemic sclerosis, lupus, and autoimmune mice","volume":"17","author":"Planque","year":"2003","journal-title":"Faseb J"},{"key":"10.1136\/ard-2021-221926_bib41","first-page":"S44","article-title":"Ccl2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSC clinical features and the effect of prostaglandin E1 treatment","volume":"30","author":"Bandinelli","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2021-221926_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2249.1999.00929.x","volume":"117","author":"Hasegawa","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard-2021-221926_bib43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/rheumatology\/ken401","article-title":"Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis","volume":"48","author":"Distler","year":"2009","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2021-221926_bib44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00002281-199911000-00010","article-title":"Abnormalities of adhesion molecules and chemokines in scleroderma","volume":"11","author":"Sato","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard-2021-221926_bib45","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.4049\/jimmunol.168.6.3088","article-title":"Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"key":"10.1136\/ard-2021-221926_bib46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/RHU.0000000000000703","article-title":"High prevalence of antithyroid antibodies in a new Zealand cohort of patients with systemic sclerosis","volume":"24","author":"Solanki","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/ard-2021-221926_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/03009742.2010.549837","article-title":"Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma","volume":"40","author":"Danielides","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard-2021-221926_bib48","author":"Consult\u00ae"},{"key":"10.1136\/ard-2021-221926_bib49","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jaci.2015.07.032","article-title":"Protein microarrays identify disease-specific anti-cytokine autoantibody profiles in the landscape of immunodeficiency","volume":"137","author":"Rosenberg","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1136\/ard-2021-221926_bib50","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724084668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724084668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2021-221926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:35:54Z","timestamp":1739522154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724084668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0003496724084668"],"URL":"https:\/\/doi.org\/10.1136\/ard-2021-221926","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2021-221926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 \u00a9 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}